‌

US Patent 11111266 Oxysterols and methods of use thereof

Patent 11111266 was granted and assigned to SAGE Therapeutics on September, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

SAGE Therapeutics

0

Current Assignee

SAGE Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Andrew Griffin0

Francesco G. Salituro0

Gabriel Martinez Botella0

Albert Jean Robichaud0

Boyd L. Harrison0

Date of Patent

September 7, 2021

0

Patent Application Number

201710180

Date Filed

October 18, 2017

0

Patent Citations Received

US Patent 12129275 Neuroactive steroids, compositions, and uses thereof

0

US Patent 11407782 Oxysterols and methods of use thereof

0

US Patent 11851457 Oxysterols and methods of use thereof

0

US Patent 11878995 Oxysterols and methods of use thereof

0

US Patent 11884697 Oxysterols and methods of use thereof

0

US Patent 11905309 Neuroactive steroids and methods of use thereof

0

US Patent 11926646 C7 substituted oxysterols and methods of use thereof

0

Patent abstract

Compounds are provided according to Formula (A): and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof; wherein R1, R2, R3, R4, R5, R6, and RG are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of conditions.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11111266 Oxysterols and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool